Human Papillomavirus

Age, Race, Sex Affect Survival for Patients With HPV-Associated Cancers

Age, Race, Sex Affect Survival for Patients With HPV-Associated Cancers

By

Using a data sample from the CDC National Program for Cancer Registries, investigators determined how demographic factors — age, race, and sex — impact 5-year survival rates for HPV-associated cancers from initial diagnosis until death.

Incidence of Invasive Cervical Cancer May Not Be Affected by HIV Status

Incidence of Invasive Cervical Cancer May Not Be Affected by HIV Status

By

HIV infection may not have a contributory effect on the incidence of invasive cervical cancer (ICC) in women as they age.

Pembrolizumab Use With CRT Safe in Locally Advanced HNSCC

Pembrolizumab Use With CRT Safe in Locally Advanced HNSCC

By

Small study also showed that pembrolizumab does not significant impair radiation or chemotherapy dosing.

Education and Coaching Are Necessary to Treat Oropharyngeal Cancers After Chemoradiotherapy

Education and Coaching Are Necessary to Treat Oropharyngeal Cancers After Chemoradiotherapy

By

A literature review noted improvements in quality of life after patients were coached and educated following radiotherapy for HPV-associated oropharyngeal cancers.

Presence of Protein E6 Predictive of Oropharyngeal Cancer Risk in HPV16-Infected Persons

Presence of Protein E6 Predictive of Oropharyngeal Cancer Risk in HPV16-Infected Persons

By

Protein produced by chronically infected cells in persons with HPV16 infection serves as a biomarker for risk of cancer of the oropharynx.

Parental Self-persuasion in Low-Income Groups Improves HPV Vaccination Rates

Parental Self-persuasion in Low-Income Groups Improves HPV Vaccination Rates

By

Self-persuasion is more effective than external persuasion for motivating low-income parents to vaccinate their children against HPV.

HPV Vaccination Program Reduces Cervical Cell Anomalies in Young Women

HPV Vaccination Program Reduces Cervical Cell Anomalies in Young Women

By

Fewer cervical cell anomalies were present on cervical cancer screens of young women in Canada who received the HPV vaccine through a school-based program.

More Than HPV Vaccine Uptake Is Needed to Reduce the Burden of HPV-associated Cancers

More Than HPV Vaccine Uptake Is Needed to Reduce the Burden of HPV-associated Cancers

By

Although HPV vaccination is expected to decrease the cancer burden from HPV across all racial and ethnic groups, some disparities are expected to persist and widen if their causes are not addressed, including lack of access to screening, timely diagnoses, and treatment.

Canadian Vaccination Programs Encouraged to Extend HPV Vaccine to Males

Canadian Vaccination Programs Encouraged to Extend HPV Vaccine to Males

By

An analysis has recommended expanding HPV vaccination programs to include males in Canada because it will help protect them against HPV-related cancers.

HPV16 DNA in oral rinse found to be prognostic of oropharyngeal cancer recurrence

By

Oropharyngeal cancer patients with detectable traces of human papillomavirus type 16 (HPV16) in their saliva after cancer treatment are at an increased risk for recurrence.

Blood antibodies may predict survival of HPV-positive oropharyngeal cancer

By

The presence of certain human papillomavirus (HPV)-16 antibodies in the blood is associated with improved survival rates for patients with HPV-related oropharyngeal carcinoma.

HPV-positive oropharyngeal cancer has cure potential

HPV-positive oropharyngeal cancer has cure potential

By

A prospective study found that patients with human papillomavirus-related disease had better treatment response than HPV-negative patients.

New approach pioneered for treating HPV-related cervical cancer

By

A drug typically used to treat infection of the retina in people with AIDS has been shown, for the first time, to sensitize cervical cancer to both chemotherapy and radiotherapy.

Biomarkers predict effectiveness of radiation treatments for head and neck cancer

By

An international team of researchers identified two biomarkers that were good at predicting a patient's resistance to radiation therapy for squamous cell cancer of the head and neck.

Number of cancer stem cells may not predict outcome in HPV-related oral cancers

By

The quality of cancer stem cells, rather than their quantity, may be the factor that leads to better survival in certain patients with oral cancer.

Systematic and comprehensive genomic study of cervical cancer completed

By

Researchers from Boston, Massachusetts; Mexico; and Norway have completed a comprehensive genomic analysis of cervical cancer in two patient populations.

HPV linked to growing number of young adults with oropharyngeal cancer

By

The human papillomavirus (HPV) may be to blame for the alarming increase of young adults with oropharyngeal cancer.

Antiviral therapy may trigger some genetic variants of cervical cancer

By

A new understanding of the genetic process that can lead to cervical cancer may help improve diagnosis of potentially dangerous lesions for some women.

Biomarker promising for predicting HPV-related oropharynx cancer

By

Antibodies against the human papillomavirus (HPV) may help identify those with a greatly increased risk for HPV-related cancer of the oropharynx.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs